Your browser doesn't support javascript.
loading
Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults.
Fries, Louis; Shinde, Vivek; Stoddard, Jeffrey J; Thomas, D Nigel; Kpamegan, Eloi; Lu, Hanxin; Smith, Gale; Hickman, Somia P; Piedra, Pedro; Glenn, Gregory M.
Affiliation
  • Fries L; Novavax, Inc, 20 Firstfield Road, Gaithersburg, MD 20878 USA.
  • Shinde V; Novavax, Inc, 20 Firstfield Road, Gaithersburg, MD 20878 USA.
  • Stoddard JJ; Novavax, Inc, 20 Firstfield Road, Gaithersburg, MD 20878 USA.
  • Thomas DN; Novavax, Inc, 20 Firstfield Road, Gaithersburg, MD 20878 USA.
  • Kpamegan E; Novavax, Inc, 20 Firstfield Road, Gaithersburg, MD 20878 USA.
  • Lu H; Novavax, Inc, 20 Firstfield Road, Gaithersburg, MD 20878 USA.
  • Smith G; Novavax, Inc, 20 Firstfield Road, Gaithersburg, MD 20878 USA.
  • Hickman SP; Novavax, Inc, 20 Firstfield Road, Gaithersburg, MD 20878 USA.
  • Piedra P; Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030 USA.
  • Glenn GM; Novavax, Inc, 20 Firstfield Road, Gaithersburg, MD 20878 USA.
Immun Ageing ; 14: 8, 2017.
Article in En | MEDLINE | ID: mdl-28413427
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Immun Ageing Year: 2017 Document type: Article Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Immun Ageing Year: 2017 Document type: Article Country of publication: Reino Unido